Monthly Archives: April 2012

Setting new standards in treating hep C

Posted on by
Reply
Professor Geoff McCaughan, head of Centenary’s liver program is setting world standards for treating hep C

Professor Geoff McCaughan, head of Centenary’s liver program is setting world standards for treating hep C

The Centenary Institute has a strong interest in making sure the products of research are used in medical treatment as quickly and safely as possible. And our interest doesn’t stop at the doors of the RPA.

For the past five years, the head of the Institute’s liver unit Professor Geoff McCaughan has led an international working party of experts convened by the Asian Pacific Association for the Study of the Liver (APASL) to revise the guidelines for the study, prevention, diagnosis, management and treatment of hepatitis C in keeping with the most recent research. The latest version of their work has just been published in the journal Hepatology International, and reflects the significant international standing of the Institute’s liver group.

Continue reading →

Genetic testing for heritable heart disease cost effective

Posted on by
Reply
Dr Jodie Ingles

Dr Jodie Ingles

Genetic testing for the most common genetic heart disorder, hypertrophic cardiomyopathy, can save money as well as lives, according to a study from the Centenary Institute just published in the British journal Heart.

The research was based on data from the National Genetic Heart Disease Registry. Lead author was National Registry Coordinator, Dr Jodie Ingles and senior author, the Registry Advisory Chair, Professor Chris Semsarian.

Continue reading →

Spotlight on a Scientist: Part 3 of LB’s why I run series

Posted on by
Reply
Dr Jeff Holst

Dr Jeff Holst, Head of Origins of Cancer group at the Centenary Institute and YCF member

LB asked me the question – “So, why are you running?” At first, I thought the answer was quite simple, I’m running to raise money for my own research team who are studying melanoma, breast and prostate cancer.

That’s the easy answer, but in reality there is a fundamental principle that drives me to be involved in fundraising – specifically that medical research is underfunded, and we should be doing all we can to support it, as it in turn supports and extends our lives.

This year is a bit of a shift for me, as over the past 5 years I’ve been involved in Movember. This stemmed from my research interests in prostate cancer, which have been funded by the money raised through Movember and distributed by the Prostate Cancer Foundation of Australia. But this year, I decided rather than do nothing for a month (ie – not shaving) I would step it up and train to run the City2Surf.

Continue reading →

New hepatitis cure a sign of things to come

Posted on by
1
Professor Geoff McCaughan, Head of the Liver Immunobiology Group

Professor Geoff McCaughan, Head of the Liver Immunobiology Group

Geoff McCaughan, head of the Centenary Institute’s liver immunobiology program, has publicly welcomed the approval by the Therapeutic Goods Administration of two new drugs to treat hepatitis C. Quoted in the Sydney Morning Herald (SMH), Geoff said the new drugs, boceprevir and telaprevir—which belong to a new class of medicines known as direct-acting anti-virals—are harbingers of “a whole swag of new drugs which are in the pipeline”.

Continue reading →

Running is not riding

Posted on by
Reply
LB on her usual mode of transport, Stormy.

LB on her usual mode of transport, Stormy.

As the majority of my workout involves sitting atop a 13 year old grey thoroughbred asking him for a soft, calm and collected walk, trot and canter, this whole running thing is new to me. So the first week or real training in Centennial Park has kicked my butt a bit.

That’s not to say that riding doesn’t take a lot of energy or muscle – you try keeping a 600 kilo animal under control and doing what you want with just your arms and calves! But it’s definitely a different set of muscles, and at the end of the day I’d like a bigger reward than a carrot and a pat on the nose.

My own personal goals for this run aside, this brings me back to the promise I made to tell the stories that matter the most in fundraising, or in achieving any target. These are stories that come from the runners/fundraisers themselves – the stories of why they joined the team, why they believe in medical research to save lives, and what motivates them in their efforts.

So with that promise in mind, I shine the spotlight on Run4Research team member Anna Lawrence. Here’s what Anna had to say about why she’s running this year.

Why I Run: Anna Lawrence Chair of the YCF

Posted on by
2
Anna Lawrence

Anna Lawrence, Chair of the Young Centenary Foundation

Last year I ran the City2Surf for the first time. Well… I ran/walked it.

I was determined to run the entire way and started a training regime but after a back injury and general laziness my training kind of…fell to the wayside.

On the day of the City2Surf I decided just to see what I could do and not beat myself up if I didn’t run the entire way – I actually did an alright job and walked only up that infamous heartbreak hill and, you know, when I just really needed a break.

Continue reading →